Neumora Therapeutics Q1 EPS $(0.30) Beats $(0.33) Estimate
Benzinga Newsdesk 6 months ago
EarningsEarnings BeatsNews
Neumora Therapeutics (NASDAQ:NMRA) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.33) by 9.09 percent. This is a 28.57 percent increase over losses of $(0.42) per share
Neumora Therapeutics (NASDAQ:NMRA) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.33) by 9.09 percent. This is a 28.57 percent increase over losses of $(0.42) per share from the same period last year.